Discover
NTLA
Intellia Therapeutics, Inc.
12.02
1 x 11.96
15 x 12.09
bid
ask
+
0.00
0.00%
10 @ 04:00 PM
12.09 +0.07 (0.58%)
| Ytd | 33.70% | |
| 1y | 11.92% |
11.69
day range
12.14
7.95
52 week range
28.25
| Open | 12.00 | Prev Close | 12.02 | Low | 11.69 | High | 12.14 | Mkt Cap | 1.68B |
| Vol | 2.41M | Avg Vol | 5.55M | EPS | -3.36 | P/E | -3.58 | Forward P/E | -4.66 |
| Beta | 1.79 | Short Ratio | 7.38 | Inst. Own | 81.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 13.51 | 200-d Avg | 12.65 | 1yr Est | 23.94 |
| Income Statement | |||
| Total Revenue | 7.66M | ||
| Revenues (USD) | 7.66M | ||
| Gross Profit | 7.66M | ||
| Operating Expenses | 120.42M | ||
| Research and Development Expense | 82.60M | ||
| Selling, General and Administrative Expense | 37.82M | ||
| Operating Income | -112.76M | ||
| Net Income | -106.63M | ||
| Net Income Common Stock | -106.63M | ||
| Net Income Common Stock (USD) | -106.63M | ||
| Consolidated Income | -106.63M | ||
| Earnings per Basic Share | -0.80 | ||
| Earnings per Basic Share (USD) | -0.80 | ||
| Earnings per Diluted Share | -0.80 | ||
| Earning Before Interest & Taxes (EBIT) | -106.63M | ||
| Earning Before Interest & Taxes (USD) | -106.63M | ||
| Weighted Average Shares | 133.48M | ||
| Weighted Average Shares Diluted | 133.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 106.13M | ||
| Cash and Equivalents (USD) | 106.13M | ||
| Investments | 559.95M | ||
| Investments Current | 331.63M | ||
| Investments Non-Current | 228.32M | ||
| Trade and Non-Trade Receivables | 7.32M | ||
| Current Assets | 527.83M | ||
| Property, Plant & Equipment Net | 101.01M | ||
| Total Assets | 857.16M | ||
| Debt Current | 23.34M | ||
| Total Debt | 73.41M | ||
| Current Liabilities | 79.39M | ||
| Debt Non-Current | 50.07M | ||
| Total Liabilities | 129.46M | ||
| Accumulated Retained Earnings (Deficit) | -2.79B | ||
| Accumulated Other Comprehensive Income | -1.03M | ||
| Shareholders Equity | 727.71M | ||
| Shareholders Equity (USD) | 727.71M | ||
| Assets Non-Current | 329.33M | ||
| Total Debt (USD) | 73.41M | ||
| Liabilities Non-Current | 50.07M | ||
| Trade and Non-Trade Payables | 11.71M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.08M | ||
| Net Cash Flow from Financing | 196.12M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -28.57M | ||
| Capital Expenditure | -1.72M | ||
| Issuance (Purchase) of Equity Shares | 194.60M | ||
| Net Cash Flow from Investing | -141.57M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -139.85M | ||
| Net Cash Flow from Operations | -83.11M | ||
| Share Based Compensation | 18.08M | ||